In addition, salidroside reversed the decrease in tight junction proteins (such as claudin-5 and occludin) by inhibiting the activation of MMP-9 (a member of MMPs), which proved the improvement of BBB damage in experimental stroke rat models (Gibson et al., 2014). The gene discussed is CLDN5; the disease is Stroke.